Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX
- 1 August 1996
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 348 (9027), 584-585
- https://doi.org/10.1016/s0140-6736(96)03054-1
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Mucosal ablation using photodynamic therapy for the treatment of dysplasia: an experimental study in the normal rat stomach.Gut, 1996
- Barrett's esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancerGastrointestinal Endoscopy, 1995
- Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagusGastrointestinal Endoscopy, 1995
- Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study.Gut, 1995
- Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapyAlimentary Pharmacology & Therapeutics, 1993
- Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acidThe Lancet, 1993
- An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagusGastroenterology, 1993
- Restoration of squamous mucosa after ablation of Barrett's esophageal epitheliumGastroenterology, 1993
- Rising Incidence of Adenocarcinoma of the Esophagus and nGastric CardiaJama-Journal Of The American Medical Association, 1991
- High-grade dysplasia in the columnar-lined esophagusThe American Journal of Surgery, 1991